T2 Biosystems
TTOO
A$0.02333
Share price
-49.33%
Change (1 day)
-99.68%
Change (1 year)
Categories
Revenue for T2 Biosystems (TTOO)
Revenue in 2024 (TTM): A$11.41 Million
According to T2 Biosystems
's latest financial reports the company's current revenue (TTM 
) is A$11.78 Million. In 2023 the company made a revenue of A$10.55 Million a decrease over the revenue in the year 2022 that were of A$32.77 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for T2 Biosystems from 2013 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 (TTM) | A$11.41 M | 8.11% |
| 2023 | A$10.55 M | -67.79% |
| 2022 | A$32.77 M | -15.31% |
| 2021 | A$38.7 M | 64.14% |
| 2020 | A$23.57 M | 98.06% |
| 2019 | A$11.9 M | -20.13% |
| 2018 | A$14.9 M | 149.38% |
| 2017 | A$5.97 M | 5.62% |
| 2016 | A$5.65 M | 46.6% |
| 2015 | A$3.86 M | 2554.66% |
| 2014 | A$0.14 M | -51.24% |
| 2013 | A$0.29 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Aldeyra Therapeutics
ALDX | N/A | N/A | 🇺🇸 USA |
 CareDx CDNA | A$0.53 B | 4,412.45% | 🇺🇸 USA |